Rafferty Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 35,699 shares of REGN stock, worth $25.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
35,699
Previous 41,217 13.39%
Holding current value
$25.5 Million
Previous $43.3 Million 13.37%
% of portfolio
0.13%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $5.65 Million - $6.63 Million
-5,518 Reduced 13.39%
35,699 $37.5 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $7.02 Million - $8.51 Million
7,945 Added 23.88%
41,217 $43.3 Million
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $816,031 - $897,988
-904 Reduced 2.65%
33,272 $32 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $1.64 Million - $1.87 Million
2,121 Added 6.62%
34,176 $30 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $977,046 - $1.19 Million
1,411 Added 4.6%
32,055 $26.4 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $3.48 Million - $4.13 Million
4,971 Added 19.36%
30,644 $22 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $247,698 - $301,017
-364 Reduced 1.4%
25,673 $21.1 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $878,833 - $954,155
1,245 Added 5.02%
26,037 $18.8 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $2.56 Million - $3.24 Million
4,467 Added 21.98%
24,792 $17.1 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $491,869 - $662,739
-897 Reduced 4.23%
20,325 $12 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $1.87 Million - $2.19 Million
3,136 Added 17.34%
21,222 $14.8 Million
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $1.9 Million - $2.34 Million
3,487 Added 23.89%
18,086 $11.4 Million
Q3 2021

Nov 10, 2021
BUY
$574.03 - $680.96 $381,729 - $452,838
665 Added 4.77%
14,599 $8.84 Million
Q2 2021

Aug 10, 2021
SELL
$472.8 - $558.54 $1.27 Million - $1.5 Million
-2,691 Reduced 16.19%
13,934 $7.78 Million
Q1 2021

May 10, 2021
BUY
$446.73 - $548.2 $2.44 Million - $3 Million
5,466 Added 48.98%
16,625 $7.87 Million
Q4 2020

Feb 10, 2021
BUY
$478.3 - $607.98 $237,715 - $302,166
497 Added 4.66%
11,159 $5.39 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $930,433 - $1.12 Million
1,708 Added 19.08%
10,662 $5.97 Million
Q2 2020

Aug 07, 2020
BUY
$493.32 - $643.92 $361,603 - $471,993
733 Added 8.92%
8,954 $5.58 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $3.92 Million - $5.76 Million
-11,646 Reduced 58.62%
8,221 $4.01 Million
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $2.88 Million - $3.95 Million
-10,489 Reduced 34.55%
19,867 $7.46 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $1.68 Million - $1.96 Million
6,157 Added 25.44%
30,356 $8.42 Million
Q2 2019

Aug 09, 2019
BUY
$299.6 - $414.82 $2.01 Million - $2.78 Million
6,710 Added 38.37%
24,199 $7.57 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $4.81 Million - $5.68 Million
12,926 Added 283.28%
17,489 $7.18 Million
Q4 2018

Feb 11, 2019
SELL
$335.82 - $403.04 $268,991 - $322,835
-801 Reduced 14.93%
4,563 $1.7 Million
Q3 2018

Nov 09, 2018
SELL
$351.14 - $408.51 $14,045 - $16,340
-40 Reduced 0.74%
5,364 $2.17 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $122,662 - $148,690
431 Added 8.67%
5,404 $1.86 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $374,562 - $467,023
1,186 Added 31.32%
4,973 $1.71 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $477,695 - $625,973
-1,332 Reduced 26.02%
3,787 $1.42 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $2.21 Million - $2.58 Million
5,119
5,119 $2.29 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email